Exploring the groundbreaking genetic engineering breakthroughs presented at TT2019, the 15th Transgenic Technology Meeting in Kobe, Japan
Every April, the city of Kobe, Japan, undergoes a remarkable transformation. As the cherry blossoms reach their peak, painting the city in shades of pink and white, another kind of blooming occurs inside the Kobe International Conference Center—where the world's leading genetic engineers gather to redefine the very boundaries of life itself. In early April 2019, this scenic coastal city hosted a milestone event: the 15th Transgenic Technology Meeting (TT2019), bringing together over 380 delegates from around the world to share breakthroughs in genetic engineering 2 3 . The meeting came at a pivotal moment—as a powerful new gene-editing technology called CRISPR was revolutionizing what's possible in biology and medicine.
Over 380 delegates from around the world gathered to share groundbreaking research in genetic engineering.
CRISPR technologies were transforming approaches to developing genetically engineered animal resources.
For decades, scientists have tampered with genetic codes, but recent advances have accelerated our capabilities at an unprecedented pace. The TT2019 meeting served as a perfect snapshot of this rapid evolution, showcasing everything from climate-resistant crops to potential cures for genetic disorders. As one report noted, the conference highlighted how CRISPR technologies were "transforming how we approach the development of genetically engineered animal resources" and pushing into "new frontiers in animal transgenesis" 6 7 . This wasn't just another scientific meeting—it was a glimpse into a future where genetic diseases could be eliminated, where organs for transplantation could be grown in animals, and where the very blueprint of life becomes as editable as a text document.
At its core, transgenesis involves transferring genes from one species to another, creating organisms that carry genetic material from unrelated species. This technology has been evolving for nearly four decades, allowing scientists to link specific genes to their functions 6 .
Imagine being able to give a mouse a human gene for disease resistance, or modify a crop to produce essential nutrients it normally lacks—these are the powerful applications of transgenic technology.
The field has undergone several revolutionary phases. Early methods were crude, expensive, and inefficient—like trying to edit a book with scissors and glue. Then came more precise techniques, and finally, in recent years, the CRISPR-Cas9 system has emerged as a revolutionary tool that has democratized and accelerated genetic engineering across countless species 7 .
If traditional genetic engineering was like using a typewriter—where making changes required cumbersome processes—CRISPR is like using a word processor with search-and-replace function. This bacterial defense system has been repurposed as a programmable gene-editing tool that can snip DNA at precise locations and either disable genes or insert new genetic sequences.
At TT2019, CRISPR dominated the conversation, appearing in contexts ranging from mouse genetics to applications in "nonconventional animal models and large mammalian species in biomedical and industrial settings" 7 . The technology was not just theoretical—presenters showed how it was being used to create better models of human diseases, improve livestock for agriculture, and even rescue endangered species.
While CRISPR captured much of the spotlight, presenters emphasized that traditional genetic engineering methods remain essential for complex genetic modifications. RNA interference, recombinant DNA technology, and advanced reproductive techniques all received attention as crucial tools that complement genome editing rather than being replaced by it 7 .
The technique used to create Dolly the sheep remains important for certain applications where CRISPR alone is insufficient.
A biological process where RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules.
DNA molecules formed by laboratory methods of genetic recombination to bring together genetic material from multiple sources.
One of the most striking experiments presented at TT2019 came from Hui Yang of the Chinese Academy of Sciences, who reported on creating functional rat brain tissue in mice—a remarkable feat of interspecies organogenesis .
First, the researchers identified a gene crucial for forebrain development in mice.
Using CRISPR-Cas9, they deleted this organogenesis-relevant gene in mouse embryos, creating a genetic "niche" that the mouse couldn't fill on its own.
Rat embryonic stem cells were injected into these genetically modified mouse blastocysts (early-stage embryos).
The complemented blastocysts were transferred to surrogate mouse mothers.
As the embryos developed, the rat cells migrated to fill the neurological void, developing into functional rat forebrain tissue within the mice.
The experiment resulted in the successful generation of functional rat cell-reconstituted forebrains in mice. These hybrid brains not only developed properly but also showed evidence of functioning integration with the rest of the mouse's neural system .
| Aspect | Finding | Implication |
|---|---|---|
| Viability | Rat forebrain tissue successfully developed in mice | Cross-species organ development is possible |
| Function | Rat-derived neural tissue appeared functional | Created tissue may be useful for research and medicine |
| Efficiency | Method allowed rapid screening of organogenesis genes | Technique can accelerate research on organ development |
| Applications | Platform for studying interspecies organogenesis | Potential future for growing human organs in animals |
This breakthrough has profound implications:
Creating genetically modified organisms requires specialized tools and reagents—the essential ingredients in the genetic engineer's toolkit. At TT2019, workshops and technical sessions highlighted both cutting-edge and foundational tools that enable today's breakthroughs.
| Tool/Technique | Function | Example Applications |
|---|---|---|
| CRISPR-Cas9 | Precise gene editing using guide RNA and Cas9 nuclease | Creating disease models, correcting genetic defects |
| Embryonic Stem (ES) Cells | Pluripotent cells that can contribute to any tissue | Generating transgenic animals, studying development |
| Zygote Electroporation | Introducing DNA/RNA into fertilized eggs using electrical currents | Efficient delivery of CRISPR components |
| Somatic Cell Nuclear Transfer | Transferring nuclei from somatic cells into enucleated eggs | Cloning, generating genetically identical animals |
| Reporter Genes | Markers that allow visualization of gene activity | Tracking which cells express modified genes |
| Organism | Research Advantages | TT2019 Highlights |
|---|---|---|
| Mice | Similar physiology to humans, well-mapped genetics | CRISPR disease models, interspecies brain studies |
| Zebrafish | Transparent embryos, rapid development | Microinjection techniques, developmental studies |
| C. elegans | Simple nervous system, fully mapped neural connections | Maternal nutrition studies using CRISPR |
| Livestock | Agricultural importance, similar organ size to humans | Gene editing for disease resistance, pharmaceutical production |
| Cuttlefish | Complex camouflage behavior, large neurons | Neural activity visualization during behavior |
Genome Editing via Oviductal Nucleic Acids Delivery - a simplified approach for in vivo gene editing that doesn't require extracting embryos 4 .
These unique cells—containing only a single set of chromosomes—simplify genetic screening and modification .
Basic methods for mouse, zebrafish, and Xenopus embryos remain essential skills, as evidenced by their inclusion in post-conference workshops 4 .
The presentations at TT2019 made clear that genetic technologies are advancing faster than our social, ethical, and regulatory frameworks can keep up with. Alison Van Eenennaam from UC Davis addressed the challenging landscape for commercializing genetically engineered food animals, noting that despite 35 years of development, only one GE food animal (AquAdvantage salmon) has reached the market . She argued for incorporating cost-benefit analyses into regulatory decisions to avoid "precluding the adoption of safe breeding innovations."
The ability to create increasingly complex genetic modifications—including human-animal chimeras—raised important ethical questions that were discussed throughout the meeting.
As these technologies advance, society will need to balance potential benefits against moral concerns about:
The future directions hinted at throughout TT2019 suggest several exciting trajectories:
The 15th Transgenic Technology Meeting in Kobe represented both a celebration of how far we've come and a preview of where genetic engineering is headed. As one report concluded, TT2019 ended "with a widely shared appreciation of the current field and hints for future directions of animal transgenesis" 7 . The technologies showcased—from the now-established CRISPR revolution to the mind-bending possibility of growing organs across species boundaries—suggest that we're standing at the threshold of a new era in biology.
What makes this moment particularly exciting is that these technologies are becoming increasingly accessible, moving from specialized laboratories to broader scientific communities. The post-conference workshop at RIKEN Center for Biosystems Dynamics Research, where fifteen participants received hands-on training in the latest techniques, exemplified this democratization of knowledge 4 . As these skills spread, the pace of discovery will only accelerate.
The work presented at TT2019 reminds us that the language of DNA—once considered the immutable text of life—has become dynamic and editable. The scientists gathering in the cherry blossom-filled city of Kobe were not just reading life's code, but learning to rewrite it. As this knowledge grows, so does our potential to address some of humanity's most pressing challenges, from disease to food security to organ transplantation. The future of genetic engineering is being written, one precise edit at a time.